Clinical Trials Directory

Trials / Completed

CompletedNCT01151657

Probiotics for Irritable Bowel Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of Southern Denmark · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The study aims to investigate the effect of probiotics on IBS-patients symptoms compared to placebo, when given for 6 months. By draw the investigators give IBS patients, in the age of 18-50 years, capsules with either probiotics or placebo. The patients are to take 2x2 capsules / day for 6 months. The patients are followed for 1 year. They are seen after 3, 6 and 12 months, and are followed by means of monthly letters. The capsules contain 3 different probiotic strains - Lactobacillus paracasei ssp paracasei F19, Lactobacillus acidophilus La5 and Bifidobacterium Bb12. The dose is 2 x 109 - 10 x 109 CFU/capsule. The hypothesis is, that there is a clinical difference between the group receiving probiotics and the group receiving placebo.

Detailed description

Background: In management of IBS, no treatments have showed great efficacy. IBS is a non-fatal disease, so safety is a high priority in the choice of treatment. Probiotics is a dietary supplement and have no adverse effects. In some studies it has shown beneficial effect on some of the IBS patients symptoms, but some of the results are questionable. The studies have to be of longer duration, with more patients and the probiotics have to be capsules instead of milk based drinks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticsCapsules with probiotics containing the strains : Lactobacillus paracasei ssp paracasei F19, Lactobacillus acidophilus La5 og Bifidobacterium Bb12. Dose/capsule : 2 x 109 - 10 x 109 CFU.
DIETARY_SUPPLEMENTPlaceboPlacebo capsules containing maltodextrin

Timeline

Start date
2009-01-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2010-06-28
Last updated
2011-10-25

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01151657. Inclusion in this directory is not an endorsement.